Pfizer Inc (PFE)

Operating return on assets (Operating ROA)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	-17,800,000	-6,774,000	4,877,000	15,085,000	16,373,000	15,970,000	14,391,000	8,361,000	3,385,000	4,276,000	-1,246,000	-4,435,000	-5,396,000	-7,503,000	-6,189,000	-4,809,000	-5,087,000	-4,436,000	-3,542,000	-3,884,000
Total assets	US$ in thousands	227,000,000	215,021,000	220,000,000	195,617,000	197,000,000	195,350,000	195,290,000	183,841,000	181,000,000	179,188,000	169,920,000	158,818,000	154,229,000	178,983,000	178,000,000	166,000,000	167,594,000	170,000,000	156,000,000	155,421,000
Operating ROA		-7.84%	-3.15%	2.22%	7.71%	8.31%	8.18%	7.37%	4.55%	1.87%	2.39%	-0.73%	-2.79%	-3.50%	-4.19%	-3.48%	-2.90%	-3.04%	-2.61%	-2.27%	-2.50%

December 31, 2023 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $-17,800,000K ÷ $227,000,000K
= -7.84%

Pfizer Inc.'s operating return on assets (operating ROA) has shown some fluctuation over the past eight quarters. In Q1 2022, the operating ROA stood at 13.86%, and this figure consistently increased over the next three quarters, reaching its peak at 18.90% in Q4 2022. However, in Q1 2023, there was a significant decline in the operating ROA to 17.22%, followed by further decreases in the subsequent quarters.

Overall, Pfizer Inc.'s operating ROA has displayed a general downward trend from Q1 2023 to Q4 2023. This suggests that the company's ability to generate operating profits from its assets has weakened over this period. It would be important for stakeholders to closely monitor the company's operational efficiency and profitability to understand the factors driving these fluctuations in operating ROA.